These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10399367)

  • 1. [Factor V: Dr. Jekyll or Mr. Hyde?].
    Prisco D
    Ann Ital Med Int; 1999; 14(2):71-3. PubMed ID: 10399367
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor V: a combination of Dr Jekyll and Mr Hyde.
    Mann KG; Kalafatis M
    Blood; 2003 Jan; 101(1):20-30. PubMed ID: 12393635
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet regulation of thrombin generation in cardiovascular disease.
    Bouchard BA; Tracy PB
    Ital Heart J; 2001 Nov; 2(11):819-23. PubMed ID: 11770866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic deep vein thrombosis in siblings with homozygous factor V Leiden mutation.
    Köppel H; Renner W; Seinost G; Pilger E
    Thromb Haemost; 2001 Mar; 85(3):562-3. PubMed ID: 11307833
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
    Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
    Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
    Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
    Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden thrombophilia: presentation of three patients and a literature review.
    Cruz-Amy M; Hunter-Mellado R
    Bol Asoc Med P R; 2006; 98(3):213-21. PubMed ID: 19610561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The concomitant presence of prohemorrhagic and thrombophilic changes in coagulation factor V: a severe defect of coagulant activity and homozygote resistance to activated protein C].
    Rossi V; Di Rocco N; Del Sonno C; Crivelli S
    Ann Ital Med Int; 1999; 14(2):127-9. PubMed ID: 10399376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on hereditary deficiency of coagulation factor V].
    Xie F; Cheng F; Zhu X
    Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):453-6. PubMed ID: 11758222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of coagulation factor V and factor Va with platelets.
    Tracy PB; Peterson JM; Nesheim ME; McDuffie FC; Mann KG
    J Biol Chem; 1979 Oct; 254(20):10354-61. PubMed ID: 114524
    [No Abstract]   [Full Text] [Related]  

  • 11. Dr. Jekyll or Mr. Hyde.
    J Fla Med Assoc; 1971 Sep; 58(9):57. PubMed ID: 4398181
    [No Abstract]   [Full Text] [Related]  

  • 12. Epinephrine in septic shock: Dr. Jekyll or Mr. Hyde?
    Levy B
    Crit Care Med; 2003 Jun; 31(6):1866-7. PubMed ID: 12794435
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor immunity and autoimmunity: a case of Dr. Jekyll and Mr. Hyde.
    Reeves WH
    Clin Immunol; 2001 Aug; 100(2):129-33. PubMed ID: 11465940
    [No Abstract]   [Full Text] [Related]  

  • 14. The anesthesiologist: from Mr. Hyde to Dr. Jekyll.
    Thomas BJ
    RN; 1974 Jan; 37(1):46-53. PubMed ID: 4492376
    [No Abstract]   [Full Text] [Related]  

  • 15. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
    Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
    Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From general systems theory to fuzzy theory, or: Dr. Jekyll and Mr. Hyde in science and technology].
    Seising R
    Technikgeschichte; 2000; 67(4):275-301. PubMed ID: 19119520
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor V G1691A, apo E4 allele, hyperhomocysteinemia and MTHFR C677T in a young patient with myocardial infarction.
    Assanelli D; Ferrari R; Bollani G; Ettori F; Bonetti P; Bersatti F; Archetti S; Ruggeri G; Bonanome A; Martini G
    Thromb Haemost; 1999 Sep; 82(3):1196. PubMed ID: 10494787
    [No Abstract]   [Full Text] [Related]  

  • 18. Quebec platelet disorder: features, pathogenesis and treatment.
    Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.
    Brüggemann LW; Schoenmakers SH; Groot AP; Reitsma PH; Spek CA
    Crit Care Med; 2006 Aug; 34(8):2201-6. PubMed ID: 16775574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.